Download | June 5, 2006

Wave Bioreactors Added To Macrogenics cGMP Manufacturing Facility

Source: Wave Biotech (Now Part Of GE Healthcare)

Wave Biotech, LLC has announced that MacroGenics, a biotechnology company headquartered in Rockville, Maryland, has installed 200-liter Wave Bioreactors® in its new facility. The Wave Bioreactors will enable MacroGenics - which is focused on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases - to produce monoclonal antibodies under current Good Manufacturing Practice (cGMP) standards.

access the Download!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online